Cellectar Biosciences Non-GAAP EPS of -$1.33
Source: SeekingAlpha
2026-05-14 07:18:17 ET
More on Cellectar Biosciences
- Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Cellectar Biosciences
- Historical earnings data for Cellectar Biosciences
- Financial information for Cellectar Biosciences
Read the full article on Seeking Alpha
For further details see:
Cellectar Biosciences Non-GAAP EPS of -$1.33
Cellectar Biosciences Inc.
NASDAQ: CLRB
CLRB Trading
-1.56% G/L:
$2.525 Last:
11,882 Volume:
$2.51 Open:
CLRB Latest News
June 01, 2026 08:05:00 am
Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting
May 14, 2026 07:15:00 am
Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
$14,077,245
4,026,431
N/A
18
N/A
Biotechnology & Life Sciences
Healthcare
US
Florham Park
